57 related articles for article (PubMed ID: 17366619)
41. Differences in genetic variation in antigen-processing machinery components and association with cervical carcinoma risk in two Indonesian populations.
Mehta AM; Spaans VM; Mahendra NB; Osse EM; Vet JN; Purwoto G; Surya IG; Cornian S; Peters AA; Fleuren GJ; Jordanova ES
Immunogenetics; 2015 Jun; 67(5-6):267-75. PubMed ID: 25796583
[TBL] [Abstract][Full Text] [Related]
42. Single nucleotide polymorphisms in antigen processing machinery component ERAP1 significantly associate with clinical outcome in cervical carcinoma.
Mehta AM; Jordanova ES; Corver WE; van Wezel T; Uh HW; Kenter GG; Jan Fleuren G
Genes Chromosomes Cancer; 2009 May; 48(5):410-8. PubMed ID: 19202550
[TBL] [Abstract][Full Text] [Related]
43. Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis.
Maksymowych WP; Inman RD; Gladman DD; Reeve JP; Pope A; Rahman P
Arthritis Rheum; 2009 May; 60(5):1317-23. PubMed ID: 19404951
[TBL] [Abstract][Full Text] [Related]
44. Variation in HLA class I antigen-processing genes and susceptibility to human papillomavirus type 16-associated cervical cancer.
Deshpande A; Wheeler CM; Hunt WC; Peyton CL; White PS; Valdez YE; Nolan JP
J Infect Dis; 2008 Feb; 197(3):371-81. PubMed ID: 18248301
[TBL] [Abstract][Full Text] [Related]
45. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.
Mehta AM; Jordanova ES; Kenter GG; Ferrone S; Fleuren GJ
Cancer Immunol Immunother; 2008 Feb; 57(2):197-206. PubMed ID: 17622526
[TBL] [Abstract][Full Text] [Related]
46. Genetic variation of antigen processing machinery components and association with cervical carcinoma.
Mehta AM; Jordanova ES; van Wezel T; Uh HW; Corver WE; Kwappenberg KM; Verduijn W; Kenter GG; van der Burg SH; Fleuren GJ
Genes Chromosomes Cancer; 2007 Jun; 46(6):577-86. PubMed ID: 17366619
[TBL] [Abstract][Full Text] [Related]
47. [Involvement of TAP2 and LMP7 gene polymorphisms in HCV infection].
Kuzushita N; Sugimoto Y; Sasaki Y; Hayashi N
Nihon Rinsho; 2001 Jul; 59(7):1248-53. PubMed ID: 11494532
[TBL] [Abstract][Full Text] [Related]
48. MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells.
Leone P; Shin EC; Perosa F; Vacca A; Dammacco F; Racanelli V
J Natl Cancer Inst; 2013 Aug; 105(16):1172-87. PubMed ID: 23852952
[TBL] [Abstract][Full Text] [Related]
49.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
50.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
51.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
